Ondine Biomedical Statistics

Total Valuation

AIM:OBI has a market cap or net worth of GBP 45.71 million. The enterprise value is 45.21 million.

Market Cap	45.71M
Enterprise Value	45.21M

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:OBI has 406.34 million shares outstanding. The number of shares has increased by 13.24% in one year.

Current Share Class	n/a
Shares Outstanding	406.34M
Shares Change (YoY)	+13.24%
Shares Change (QoQ)	+21.20%
Owned by Insiders (%)	39.74%
Owned by Institutions (%)	21.80%
Float	244.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.26
PB Ratio	n/a
P/TBV Ratio	4,161.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.48
EV / Sales	47.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.22

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 18.47.

Current Ratio	0.80
Quick Ratio	0.36
Debt / Equity	18.47
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-228.20

Financial Efficiency

Return on equity (ROE) is -685.59% and return on invested capital (ROIC) is -330.37%.

Return on Equity (ROE)	-685.59%
Return on Assets (ROA)	-159.71%
Return on Invested Capital (ROIC)	-330.37%
Return on Capital Employed (ROCE)	-76,865.92%
Revenue Per Employee	52,482
Profits Per Employee	-458,464
Employee Count	18
Asset Turnover	0.29
Inventory Turnover	0.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.02% in the last 52 weeks. The beta is 0.15, so AIM:OBI's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+11.02%
50-Day Moving Average	10.44
200-Day Moving Average	8.24
Relative Strength Index (RSI)	46.37
Average Volume (20 Days)	291,634

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:OBI had revenue of GBP 944,679 and -8.25 million in losses. Loss per share was -0.04.

Revenue	944,679
Gross Profit	567,154
Operating Income	-8.44M
Pretax Income	-8.25M
Net Income	-8.25M
EBITDA	-8.33M
EBIT	-8.44M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 704,173 in cash and 202,927 in debt, giving a net cash position of 501,247 or 0.00 per share.

Cash & Cash Equivalents	704,173
Total Debt	202,927
Net Cash	501,247
Net Cash Per Share	0.00
Equity (Book Value)	10,985
Book Value Per Share	0.00
Working Capital	-453,261

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.26 million and capital expenditures -7,516, giving a free cash flow of -7.27 million.

Operating Cash Flow	-7.26M
Capital Expenditures	-7,516
Free Cash Flow	-7.27M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	60.04%
Operating Margin	-893.82%
Pretax Margin	-873.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM:OBI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.24%
Shareholder Yield	-13.24%
Earnings Yield	-18.05%
FCF Yield	-15.90%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:OBI has an Altman Z-Score of -101.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-101.68
Piotroski F-Score	n/a